trending Market Intelligence /marketintelligence/en/news-insights/trending/O-9d-KMp20cASE9JzD4Czg2 content esgSubNav
In This List

Silence Therapeutics appoints chairman

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Silence Therapeutics appoints chairman

Silence Therapeutics plc appointed Annalisa Jenkins the nonexecutive chairman of the company's board of directors.

Stephen Parker, the company's former nonexecutive chairman, will transition to a nonexecutive director role.

Jenkins is the CEO of Dimension Therapeutics Inc.